XOMAP Q4 2024 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M+375.4% YoY

Gross Profit

$9M97.7% margin

Operating Income

-$16M-186.5% margin

Net Income

-$4M-45.5% margin

EPS (Diluted)

$0.82

QoQ Revenue Growth

+21.1%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$221M

Total Liabilities

$139M

Stockholders' Equity

$82M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$2M	+375.4%
Gross Profit	$9M	$2M	+370.9%
Operating Income	-$16M	-$20M	+18.5%
Net Income	-$4M	-$20M	+80.3%